Age characteristics of risk cardiovascular complications in women with left breast cancer with preserved ejection fraction at the stage of chemotherapy and radiotherapy

Aim. A study of the risk factors for middle-aged and elderly women HER2neu with negative left breast cancer and a normal ejection fraction at the stage of chemoradiotherapy in everyday clinical practice. Matherial and methods. 61 women with left breast cancer without severe cardiovascular pathology were examined at the stage of doxorubicin therapy and 3D conformal radiation therapy. Group 1 comprised 32 patients of middle age (49.8 ± 4.5 years). Group 2 comprised 29 elderly patients (68.3 ± 3.6 years). In addition to Score risk assessment, additional factors, including psychosocial factors, were studied. All patients underwent ECG, echocardiography and 24-hour ECG monitoring. Anxiety levels were assessed using the HADS scale and scale CH. D. Spielberger –Yu.L. Khanin. The study was conducted before the start of treatment, after the completion of the doxorubicin course and after the completion of the course of radiotherapy. Results with discussion. In middle-aged patients, moderate Score risk was found in 21.9%, in the elderly at 58.6% (p = 0.0043, RR 2.68, 95% CI 1.301–5.520). A high Score risk was found in 15.6% of middle-aged patients and 41.4% of elderly patients (p = 0.0438, RR 2.648, 95% CI 1061–6.607). The most common risk factors in the patients studied in addition to age were heredity, overweight, hypercholesterolemia and diabetes mellitus. All examined patients had moderate reactive anxiety. Patients of middle age have moderate personal anxiety, in elderly patients high personal anxiety. After treatment with doxorubicin in a cumulative dose not exceeding 360 mg/m2 , a reduction in the ejection fraction below 50% was found in 6 middle-aged patients and 17.2% in elderly patients. Asymptomatic diastolic dysfunction was detected in 31.3% of middle-aged patients and 55.2% of the elderly. In patients of both groups, after arranging treatment, arrhythmia was detected. Conclusions. The obtained data indicate to the need for in-depth examination of middle-aged and especially elderly patients with left breast cancer with an assessment of risk factors and conducting an in-depth examination using Echocardiography, 24-hour ECG monitoring and psychological testing to prevent and early detection of cardiovascular complications.

cardiovascular complications, risk factors, heart failure, radiation therapy, chemotherapy, left breast cancer

1. Gendlin G.E., Emelina E.I., Nikitin I.G., Vasyuk Yu.A. Modern view on cardiotoxicity of chemotherapeutics in oncology including anthracyclines. Russian Journal of Cardiology. 2017;22 (3):145–54. [Russian: Гендлин Г. Е., Емелина Е. И., Никитин И. Г., Васюк Ю. А. Современный взгляд на кардиотоксичность химиотерапии онкологических заболеваний, включающей антрациклиновые антибиотики. Российский кардиологический журнал. 2017;22(3):145-54]. DOI: 10.15829/1560-4071-2017-3-145-154

2. Emelina E.I., Gendlin G. E., Nikitin I. G. Manifestations of cardiotoxicity in patients after radiation therapy. Ural medical journal. 2017;9 (153):98–103. [Russian: Емелина Е. М., Гендлин Г. Е., Никитин И. Г. Проявления кардиотоксичности у пациентов после лучевой терапии. Уральский медицинский журнал. 2017;9(153):98-103]

3. Adão R, de Keulenaer G, Leite-Moreira A, BrásSilva C. Cardiotoxicity associated with cancer therapy: Pathophysiology and prevention. Revista Portuguesa de Cardiologia (English Edition). 2013;32(5):395–409. DOI: 10.1016/j.repce.2012.11.019

4. Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2012;23(Suppl 7):vii155-166. DOI: 10.1093/annonc/mds293

5. Hooning MJ, Botma A, Aleman BMP, Baaijens MHA, Bartelink H, Klijn JGM et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. Journal of the National Cancer Institute. 2007;99(5):365–75. DOI: 10.1093/jnci/djk064

6. Vasyuk Yu.A., Nesvetov V.V., Shkolnik E.L., Fursov S.A., Shkolnik L.D., Gendlin G.E. et al. Possibilities of modern echocardiographic technologies in the early diagnosis of the cardiotoxic effect of chemotherapy drugs anthracycline series in cancer patients. Kardiologiia. 2017;57 (S4):31–7. [Russian: Васюк Ю. А., Несветов В. В., Школьник Е. Л. Возможности современных эхокардиографических технологий в ранней диагностике кардиотоксического действия химиотерапевтических препаратов антрациклинового ряда у онкологических больных. Кардиология. 2017;57(S4):31-7]. DOI: 10.18087/cardio.2417

7. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European Heart Journal. 2016;37(36):2768–801. DOI: 10.1093/eurheartj/ehw211

8. Boytsov S.A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Yeganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;23 (6):7–122. [Russian: Бойцов С. А., Погосова Н. В., Бубнова М. Г., Драпкина О. М., Гаврилова Н. Е., Еганян Р. А. и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018;23(6):7–122]. DOI: 10.15829/1560-4071-2018-6-7-122

9. Bovelli D, Plataniotis G, Roila F, ESMO Guidelines Working Group. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2010;21(Suppl 5):v277-282. DOI: 10.1093/annonc/mdq200

10. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL et al. Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality. New England Journal of Medicine. 2015;372(14):1333–41. DOI: 10.1056/NEJMoa1406656

11. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal. 2003;24(11):987–1003. DOI: 10.1016/s0195-668x(03)00114-3

12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. Journal of the American Society of Echocardiography. 2005;18(12):1440–63. DOI: 10.1016/j.echo.2005.10.005

13. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. European Journal of Echocardiography. 2008;10(2):165–93. DOI: 10.1093/ejechocard/jep007

14. Beck AT. An Inventory for Measuring Depression. Archives of General Psychiatry. 1961;4(6):561–71. DOI: 10.1001/archpsyc.1961.01710120031004

15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361–70. PMID: 6880820

16. Batarshev A. V. Basic psychological properties and selfdetermination of personality: a Practical guide to psychological diagnosis. – SPb: Speech; 44–49 p. [Russian: Батаршев А. В. Базовые психологические свойства и самоопределение личности: Практическое руководство по психологической диагностике. – СПб.: Речь, 2005. – С.44-49]. ISBN 5-9268-0364-0

17. Balanova Yu.A., Shal’nova S.A., Deev A.D., Kapustina A.V., Konstantinov V.V., Boytsov S.A. Smoking prevalence in Russia. What has changed over 20 years? Preventive Medicine. 2015;18(6):47–52. [Russian: Баланова Ю.А., Шальнова С.А., Деев А.Д., Капустина А.В., Константинов В.В., Бойцов С.А. Распространенность курения в России. Что изменилось за 20 лет? Профилактическая медицина. 2015;18(6):47-52]

18. Chulkova V. A., Pestereva E. V. A cancer patient’s mentality. Problems in oncology. 2010;56 (1):83–7. [Russian: Чулкова В. А., Пестерева Е. В. Душевный мир онкологического больного. Вопросы онкологии. 2010;56(1):83-7]

19. Boytsov S. A., Balanova Yu. A., Shal’nova S. A., Deev A. D., Artamonova G. V., Gatagonova T. M. et al. Arterial hypertension among persons aged 25–64: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13 (4):4–14. [Russian: Бойцов С. А., Баланова Ю. А., Шальнова С. А., Деев А.Д., Артамонова Г. В., Гагатонова Т. М. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль по материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13(4):4-14]. DOI: 10.15829/1728-8800-2014-4-4-14

20. Muromtceva G.A., Kontsevaya A.V., Konstantinov V.V., Artamonova G.V., Gatagonova T. M., Duplyakov D.V. et al. The prevalence of non-infectious disease risk factors in the Russian population in 2012–2013. Results of the ESSE-RF study. Cardiovascular Therapy and Prevention. 2014;13 (6):4–11. [Russian: Муромцева Г.А., Концевая А. В., Константинов В. В., Артамонова Г. В., Гатагонова Т. М., Дупляков Д. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4-11]

21. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. New England Journal of Medicine. 2011;364(9):829–41. DOI: 10.1056/NEJMoa1008862

22. Poroshina E. G., Vologdina I. V., Pestereva E. V. Psychological characteristics and quality of life of cancer patients with concomitant cardiovascular pathology. HERALD of NorthWestern State Medical University named after I.I. Mechnikov. 2017;9 (1):83–8. [Russian: Порошина Е. Г., Вологдина И. В., Пестерева Е. В. Психологические особенности и качество жизни у онкологических больных с сочетанной сердечнососудистой патологией. Вестник СЗГМУ им. Мечникова. 2017;9(1):83-9]. DOI: 10.17816/mechnikov20179183-88